Table of Content

1 Market Overview of Anti–vascular Endothelial Growth Factor Therapy
1.1 Anti–vascular Endothelial Growth Factor Therapy Market Overview
1.1.1 Anti–vascular Endothelial Growth Factor Therapy Product Scope
1.1.2 Anti–vascular Endothelial Growth Factor Therapy Market Status and Outlook
1.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2034)
1.4 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Region (2024-2024)
1.5 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
1.6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
1.6.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
1.6.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
1.6.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
1.6.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034)
2 Anti–vascular Endothelial Growth Factor Therapy Market by Type
2.1 Introduction
2.1.1 Extraction Injection
2.1.2 Precharge Injection
2.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Type (2024-2024)
2.2.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Type (2024-2034)
3 Anti–vascular Endothelial Growth Factor Therapy Market Overview by Application
3.1 Introduction
3.1.1 Macular Degeneration
3.1.2 Nacular Edema
3.1.3 Uveitis
3.1.4 Retinal Vein Occlusion
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Application (2024-2024)
3.2.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue Breakdown by Application (2024-2034)
4 Anti–vascular Endothelial Growth Factor Therapy Competition Analysis by Players
4.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2022)
4.3 Date of Key Players Enter into Anti–vascular Endothelial Growth Factor Therapy Market
4.4 Global Top Players Anti–vascular Endothelial Growth Factor Therapy Headquarters and Area Served
4.5 Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Anti–vascular Endothelial Growth Factor Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Regeneron Pharmaceuticals (Eylea)
5.1.1 Regeneron Pharmaceuticals (Eylea) Profile
5.1.2 Regeneron Pharmaceuticals (Eylea) Main Business
5.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
5.1.4 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue (US$ Million) & (2024-2024)
5.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
5.2 Genentech
5.2.1 Genentech Profile
5.2.2 Genentech Main Business
5.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
5.2.4 Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue (US$ Million) & (2024-2024)
5.2.5 Genentech Recent Developments
5.3 Kanghong Pharmaceutical
5.3.1 Kanghong Pharmaceutical Profile
5.3.2 Kanghong Pharmaceutical Main Business
5.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
5.3.4 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue (US$ Million) & (2024-2024)
5.3.5 Recent Developments
6 North America
6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti–vascular Endothelial Growth Factor Therapy Market Dynamics
11.1 Anti–vascular Endothelial Growth Factor Therapy Industry Trends
11.2 Anti–vascular Endothelial Growth Factor Therapy Market Drivers
11.3 Anti–vascular Endothelial Growth Factor Therapy Market Challenges
11.4 Anti–vascular Endothelial Growth Factor Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Share by Region (2024-2024)
Table 4. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2024)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Table 11. North America Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2024)
Table 24. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Table 26. North America Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Anti–vascular Endothelial Growth Factor Therapy Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2022)
Table 39. Date of Key Players Enter into Anti–vascular Endothelial Growth Factor Therapy Market
Table 40. Global Anti–vascular Endothelial Growth Factor Therapy Key Players Headquarters and Area Served
Table 41. Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
Table 42. Global Anti–vascular Endothelial Growth Factor Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Regeneron Pharmaceuticals (Eylea) Basic Information List
Table 45. Regeneron Pharmaceuticals (Eylea) Description and Business Overview
Table 46. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Anti–vascular Endothelial Growth Factor Therapy Business of Regeneron Pharmaceuticals (Eylea) (2024-2024)
Table 48. Regeneron Pharmaceuticals (Eylea) Recent Developments
Table 49. Genentech Basic Information List
Table 50. Genentech Description and Business Overview
Table 51. Genentech Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Anti–vascular Endothelial Growth Factor Therapy Business of Genentech (2024-2024)
Table 53. Genentech Recent Developments
Table 54. Kanghong Pharmaceutical Basic Information List
Table 55. Kanghong Pharmaceutical Description and Business Overview
Table 56. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Anti–vascular Endothelial Growth Factor Therapy Business of Kanghong Pharmaceutical (2024-2024)
Table 58. Kanghong Pharmaceutical Recent Developments
Table 59. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 60. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 61. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 62. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 63. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 64. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 65. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 66. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2024-2024)
Table 67. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2024-2034)
Table 68. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 69. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 70. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 71. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 72. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 73. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 74. Anti–vascular Endothelial Growth Factor Therapy Market Trends
Table 75. Anti–vascular Endothelial Growth Factor Therapy Market Drivers
Table 76. Anti–vascular Endothelial Growth Factor Therapy Market Challenges
Table 77. Anti–vascular Endothelial Growth Factor Therapy Market Restraints
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Regions: 2022 VS 2034
Figure 4. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Extraction Injection
Figure 11. Global Extraction Injection Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Precharge Injection
Figure 13. Global Precharge Injection Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Share by Type: 2022 & 2034
Figure 15. North America Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Figure 16. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2034)
Figure 20. Macular Degeneration Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Nacular Edema Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Uveitis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Retinal Vein Occlusion Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Share by Application: 2022 & 2034
Figure 25. North America Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Figure 26. Europe Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2024-2034)
Figure 30. Anti–vascular Endothelial Growth Factor Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Anti–vascular Endothelial Growth Factor Therapy Market Share in 2022
Figure 32. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2024-2034)
Figure 33. United States Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 36. France Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2024-2034)
Figure 42. China Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 46. India Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2024-2034)
Figure 49. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2024-2034)
Figure 52. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Anti–vascular Endothelial Growth Factor Therapy Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report